Printer Friendly
The Free Library
14,530,717 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Lifecore Names Officers.


Business Editors/Health/Medical Writers

CHASKA, Minn.--(BUSINESS WIRE)--March 11, 2004

LIFECORE BIOMEDICAL bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (Nasdaq:LCBM) announced today that Larry Hiebert has been appointed Vice President of Operations and David Noel has been appointed Vice President of Finance and Chief Financial Officer.

"The promotions of Larry and Dave recognize their respective contributions to our company," said Dennis J. Allingham, Lifecore's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "These actions strengthen our management team and enhance our ability to execute key operating objectives, while permitting us to focus upon the strategic development of our business."

Mr. Hiebert has been the Director of Operations since 1996. He has held various manufacturing and materials management positions within the company since 1983.

Mr. Noel, a Certified Public Accountant Certified Public Accountant (CPA)

An accountant who has met certain standards, including experience, age, and licensing, and passed exams in a particular state.
, has served as the company's Controller for the past two years. Prior to joining Lifecore, Noel held senior financial management positions. His background includes a broad range of experience in public accounting, manufacturing and medical products industries.

About Lifecore Biomedical

Lifecore Biomedical develops, manufactures, and markets biomaterials and medical devices for use in various surgical markets through two divisions, Hyaluronan Division and Oral Restorative Division. The Hyaluronan Division conducts its business through OEM (Original Equipment Manufacturer) The rebranding of equipment and selling it. The term initially referred to the company that made the products (the "original" manufacturer), but eventually became widely used to refer to the organization that buys the products and  and contract manufacturing alliances in the gynecologic gynecologic /gy·ne·co·log·ic/ (gi?ne-) (jin?e-kah-loj´ik) pertaining to the female reproductive tract or to gynecology. , ophthalmic, orthopedic, and veterinary surgical fields. The Oral Restorative Division conducts its dental surgery business through direct sales and marketing in the United States, Germany, Italy, and Sweden, and through 23 distributors in 35 countries.

Forward-Looking Statements

Certain statements in this release are forward-looking statements as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995, including the statements regarding execution of key operating objectives and strategic development of the business. Such forward-looking statements involve numerous risks and uncertainties in the complex regulatory and competitive aspects of Lifecore's business activity that could cause actual results to differ materially from those implied. Investors are strongly cautioned to review more detailed discussions of those risks presented in the Company's filings with the Securities and Exchange Commission including Exhibit 99.1 to Lifecore's annual report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the fiscal year ending June 30, 2003.

Additional general corporate information is available on the internet at http://www.lifecore.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 11, 2004
Words:358
Previous Article:AmerisourceBergen Helps Hospitals and Manufacturers Respond to New FDA Barcode Regulations with Broadest Array of Solutions.
Next Article:Moldflow Executive Vice President and General Manager Adopts Rule 10b5-1 Trading Plan.
Topics:



Related Articles
Lifecore and FDA Agree to Reschedule June 4 Dispute Resolution Panel.
Lifecore Schedules September FDA Dispute Resolution Panel; Anticipates Increased Near Term Losses.
Republican Official Named.(California Republican Party names chief executive officer Ryan Erwin)(Brief Article)
Lifecore Enters New Development, License and Supply Relationship for Calcium Sulfate With Wright Medical.
Lifecore Prevails over Straumann in Trade Dress Lawsuit.
Xencor.(Biotechnology)(Harry Stylli has been named chief executive officer, president and a director and Bassil Dahiyat has been named chief...
Lifecore Names New President And CEO.
Dr. James W. Bracke Joins EPIEN Medical As COO.
Lifecore Names Martin J. Emerson to Board of Directors.
The new Syngenta/Pioneer joint venture GreenLeaf Genetics LLC names Dawn Judkins chief financial officer, Dave Gebhardt chief technology officer and...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles